<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347.2016.10.2.035-040</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-343</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ОRIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>THE STRUCTURE OF THE GENETIC POLYMORPHISMS IN PATIENTS WITH METABOLIC SYNDROME AND A COMPLICATED PREGNANCY IN HISTORY</article-title><trans-title-group xml:lang="ru"><trans-title>СТРУКТУРА ГЕНЕТИЧЕСКИХ ПОЛИМОРФИЗМОВ У РОДИЛЬНИЦ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ И ОСЛОЖНЕННЫМ ТЕЧЕНИЕМ БЕРЕМЕННОСТИ В АНАМНЕЗЕ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хромылев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khromylev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хромылев Алексей Викторович – аспирант кафедры акушерства и гинекологии. </p><p>Адрес: ул. Трубецкая, 8, стр. 2, Москва, Россия, 119048.</p></bio><bio xml:lang="en"><p>Khromylev Aleksei Viktorovich – graduate student of the Department of Obstetrics and Gynecology. </p><p>Address: ul. Trubetskaya, 8-2, Moscow, Russia, 119048.</p></bio><email xlink:type="simple">khromilev@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макацария</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Makatsariya</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макацария Александр Давидович – доктор медицинских наук, член-корреспондент РАН, профессор, заведующий кафедрой акушерства и гинекологии медико-профилактического факультета. </p><p>Адрес: ул. Трубецкая, 8, стр. 2, Москва, Россия, 119048.</p></bio><bio xml:lang="en"><p>Makatsariya Aleksandr Davidovich – MD, corresponding member of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics and Gynecology, Faculty of Medical and Preventive. </p><p>Address: ul. Trubetskaya, 8-2, Moskva, Russia, 119048. </p></bio><email xlink:type="simple">gemostasis@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет имени И.М. Сеченова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>30</day><month>10</month><year>2016</year></pub-date><volume>10</volume><issue>3</issue><fpage>35</fpage><lpage>40</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Khromylev A.V., Makatsariya A.D., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Хромылев А.В., Макацария А.Д.</copyright-holder><copyright-holder xml:lang="en">Khromylev A.V., Makatsariya A.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/343">https://www.gynecology.su/jour/article/view/343</self-uri><abstract><sec><title>Objective</title><p>Objective. To analyze the structure of the gene polymorphisms of hemostasis, platelet receptors and enzymes of the folate cycle in patients with metabolic syndrome (MS) and a complicated pregnancy in history.</p></sec><sec><title>Materials and Methods</title><p> Materials and Methods. The study included 115 patients with MS. Of these, group 1 (64 patients) had a complicated course of pregnancy in anamnesis and group 2 (51 patient) with no pregnancies in anamnesis. The control group consisted of 50 somatically healthy mothers. All the patients were carried out molecular analysis of gene polymorphisms of the hemostatic polymorphisms of platelet receptor genes, polymorphisms of genes of folate cycle enzymes by polymerase chain reaction. </p></sec><sec><title>Results</title><p>Results. In all patients with MS was identified pathology of genes of hemostasis, platelet receptors or enzymes of the folate cycle, and in all cases attended a multigenic (more than two defect genes) form of pathology. In the study, the patients with MS was significantly higher frequency of polymorphism in the gene for inhibitor of tissue plasminogen activator, in the gene of tissue plasminogen activator, fibrinogen gene, in the gene for angiotensin-converting enzyme gene of the receptor of angiotensin II 1 type. Gene polymorphisms of platelet receptors were also found significantly more often in patients with MS. Results of the study of folate cycle enzymes genes showed the prevalence of pathological polymorphisms in this group of genes in the genotype of patients with MS. In patients with MS and a complicated pregnancy in history was revealed not only a large frequency of occurrence of a pathological gene polymorphisms, but also the predominance in the structure the homozygous forms of these polymorphisms.</p></sec><sec><title>Conclusion</title><p>Conclusion. Thus, it becomes obvious pathogenetic role of latent thrombophilic states in the development of various obstetric complications in patients with MS and the reason underlying this condition is a multigenic structure of the gene polymorphisms of hemostasis, platelet receptors and enzymes of the folate cycle in all MS patients.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Цель работы – провести анализ структуры полиморфизмов генов гемостаза, рецепторов тромбоцитов и ферментов фолатного цикла у родильниц с метаболическим синдромом (МС) и осложненным течением беременности в анамнезе. </p><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование было включено 115 родильниц с МС. Из них 1-я группа (64 пациентки) имели осложненное течение беременности в анамнезе и 2-я группа (51 пациентка) – с отсутствием беременностей в анамнезе. Группу контроля составили 50 соматически здоровых родильниц. Всем пациенткам был проведен молекулярный анализ полиморфизмов генов гемостаза, полиморфизмов генов рецепторов тромбоцитов, полиморфизмов генов ферментов фолатного цикла методом полимеразной цепной реакции (ПЦР). </p></sec><sec><title>Результаты</title><p>Результаты. В результате обследования пациенток с метаболическим синдромом на широкий спектр полиморфизмов генов было выявлено наличие у всех исследуемых пациенток с МС патологии генов гемостаза, рецепторов тромбоцитов или ферментов фолатного цикла, причем во всех случаях присутствовала мультигенная (более двух дефектов генов) форма патологии генов. В ходе исследования у пациенток с МС достоверно выше была частота встречаемости полиморфизма в гене ингибитора тканевого активатора плазминогена (p&lt;0,001), в гене тканевого активатора плазминогена (p&lt;0,001), в гене фибриногена (p&lt;0,001), в гене ангиотензин-конвертирующего фермента (p&lt;0,001), в гене рецептора ангиотензина II 1-го типа (p&lt;0,001). Полиморфизмы генов тромбоцитарных рецепторов были выявлены также достоверно чаще у пациенток с МС (p&lt;0,001). Анализ результатов исследования генов ферментов фолатного цикла показал широкую распространенность патологических полиморфизмов данной группы генов в генотипе пациенток с МС. У пациенток с МС и осложненным течением беременности в анамнезе была выявлена не только большая частота встречаемости патологических полиморфизмов генов, но также преобладание в структуре гомозиготных форм данных полиморфизмов.</p></sec><sec><title>Заключение</title><p>Заключение. Таким образом, становится очевидной патогенетическая роль скрытого тромбофилического состояния в развитии различных акушерских осложнений у пациенток с МС и характерная причина, обусловливающая данное состояние, а именно выявленная у всех пациенток с МС мультигенная структура полиморфизмов генов гемостаза, рецепторов тромбоцитов и ферментов фолатного цикла.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>метаболический синдром</kwd><kwd>ожирение</kwd><kwd>полиморфизмы генов</kwd><kwd>гестационные осложнения</kwd><kwd>тромбофилия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>metabolic syndrome</kwd><kwd>obesity</kwd><kwd>gestational complications</kwd><kwd>polymorphisms</kwd><kwd>thrombophilia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Макацария А.Д., Пшеничникова Е.Б., Пшеничникова Т.Б., Бицадзе В.О. Метаболический синдром и тромбофилия в акушерстве и гинекологии. М. 2006; 480 с.</mixed-citation><mixed-citation xml:lang="en">Makatsariya A.D., Pshenichnikova E.B., Pshenichnikova T.B., Bitsadze V.O. Metabolic syndrome and thrombophilia in obstetrics and gynecology [Metabolicheskii sindrom i trombofiliya v akusherstve i ginekologii (in Russian)]. Moscow. 2006; 480 s.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Alessi M.C., Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thrombosis and Haemostasis. 2008; 99: 995-1000.</mixed-citation><mixed-citation xml:lang="en">Alessi M.C., Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thrombosis and Haemostasis. 2008; 99: 995-1000.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Anfossi G., Russo I., Trovati M. Platelet dysfunction in central obesity. Nutrition, Metabolism, and Cardiovascular Diseases. 2009; 19: 440-419.</mixed-citation><mixed-citation xml:lang="en">Anfossi G., Russo I., Trovati M. Platelet dysfunction in central obesity. Nutrition, Metabolism, and Cardiovascular Diseases. 2009; 19: 440-419.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Badimon L., Hernandez Vera R., Vilahur G. Atherothrombotic risk in obesity. Hamostaseologie. 2013; 33: 259-68.</mixed-citation><mixed-citation xml:lang="en">Badimon L., Hernandez Vera R., Vilahur G. Atherothrombotic risk in obesity. Hamostaseologie. 2013; 33: 259-68.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bates S.M., Greer I.A., Pabinger I. et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133: 844-886.</mixed-citation><mixed-citation xml:lang="en">Bates S.M., Greer I.A., Pabinger I. et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133: 844-886.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Franchini M., Targher G., Montagnana M., Lippi G. The metabolic syndrome and the risk of arterial and venousthrombosis. Thrombosis Research. 2008; 122: 727-735.</mixed-citation><mixed-citation xml:lang="en">Franchini M., Targher G., Montagnana M., Lippi G. The metabolic syndrome and the risk of arterial and venousthrombosis. Thrombosis Research. 2008; 122: 727-735.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J.A., Montagnani M., Koh K.K., Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006; 113: 1888-1904.</mixed-citation><mixed-citation xml:lang="en">Kim J.A., Montagnani M., Koh K.K., Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006; 113: 1888-1904.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010; 314: 1-16.</mixed-citation><mixed-citation xml:lang="en">Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010; 314: 1-16.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mina A., Favaloro E.J., Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Seminars in Thrombosis and Hemostasis. 2007; 33: 798-809.</mixed-citation><mixed-citation xml:lang="en">Mina A., Favaloro E.J., Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Seminars in Thrombosis and Hemostasis. 2007; 33: 798-809.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nieuwdorp M., Stroes E.S., Meijers J.C., Buller H. Hypercoagulability in the metabolic syndrome. Current Opinion in harmacology. 2005; 5: 155-159.</mixed-citation><mixed-citation xml:lang="en">Nieuwdorp M., Stroes E.S., Meijers J.C., Buller H. Hypercoagulability in the metabolic syndrome. Current Opinion in harmacology. 2005; 5: 155-159.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Palomo I., Alarcon M., Moore-Carrasco R., Argiles J.M. Hemostasis alterations in metabolic syndrome. International Journal of Molecular Medicine. 2006; 18: 969-974.</mixed-citation><mixed-citation xml:lang="en">Palomo I., Alarcon M., Moore-Carrasco R., Argiles J.M. Hemostasis alterations in metabolic syndrome. International Journal of Molecular Medicine. 2006; 18: 969-974.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Randriamboavonjy V., Fleming I. Insulin, insulin resistance, and platelet signaling in diabetes. Diabetes Care. 2009; 32: 528-530.</mixed-citation><mixed-citation xml:lang="en">Randriamboavonjy V., Fleming I. Insulin, insulin resistance, and platelet signaling in diabetes. Diabetes Care. 2009; 32: 528-530.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Robertson L., Wu O., Langhorne P. et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006; 132: 171-196.</mixed-citation><mixed-citation xml:lang="en">Robertson L., Wu O., Langhorne P. et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006; 132: 171-196.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
